Peptide record

TPDB10956

maximin5 Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity standard
27 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10956
maximin5
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF pep-lab AFP-GFuse Antifungipept CAFPdb AI4AVP dbAMP 3.0 DRAVP 2.0
standard
No
A 27-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
SIGAKILGGVKTFFKGALKELASTYLQ
Physicochemical Analysis
C133H218N32O36
RNDCHMPW
GLK
2841.39
10.31
4
1
13
+3
0.64
0.404
108.52
Mammalian: 1.9 hour Yeast: >20 hour E.coli: >10 hour
1490
52.44
6
Residue Composition
number
3
A
0
R
0
N
0
D
0
C
1
E
1
Q
4
G
0
H
2
I
4
L
4
K
0
M
2
F
0
P
2
S
2
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 3 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 1 G: 4 H: 0 I: 2 L: 4 K: 4 M: 0 F: 2 P: 0 S: 2 T: 2 W: 0 Y: 1 V: 1
Chemical Descriptors
27
C133H218N32O36
2841.39
10.31
+3
0.64
0.404
Free
L
Linear
Free
Antimicrobial
Bombina maxima
Evidence Records 37 records
Evidence 1 Activity

Activity

MIC
Antibacterial
3.6 µM

Target

Staphylococcus aureus ATCC2592

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E.coli ATCC25922 (ND), S. aureus ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 1
Evidence 2 Activity

Activity

MIC
Antibacterial
7.2 µM

Target

B. pyocyaneus CMCCB10104

Source & Reference

dbAMP DRAMP

Other

Active against E.coli ATCC25922 (ND), S. aureus ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. a
Evidence 3 Activity

Activity

MIC
Antibacterial
12 µM

Target

B. megatherium

Source & Reference

dbAMP DRAMP

Other

li ATCC25922 (ND), S. aureus ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM
Evidence 4 Activity

Activity

MIC
Antibacterial
12 µM

Target

B. dysenterium

Source & Reference

dbAMP DRAMP

Other

ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 1
Evidence 5 Activity

Activity

MIC
Antibacterial
3.6 µM

Target

Klebsiella pneumoniae

Source & Reference

dbAMP DRAMP

Other

ocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFF
Evidence 6 Activity

Activity

MIC
Antibacterial
1.2 µM

Target

Candida albicans ATCC2002

Source & Reference

dbAMP DRAMP

Other

uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFFI2001 (MIC 12 ug/ml). active only a
Evidence 7 Activity

Activity

MIC
Antibacterial
12 µg/mL

Target

A. flavus IFFI4015

Source & Reference

dbAMP DRAMP

Other

. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFFI2001 (MIC 12 ug/ml). active only against cancer cells C8166 (IC50 34.
Evidence 8 Activity

Activity

MIC
Antibacterial
12 µg/mL

Target

P. uticale IFFI2001

Source & Reference

dbAMP DRAMP

Other

e (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFFI2001 (MIC 12 ug/ml). active only against cancer cells C8166 (IC50 34.4 ug/ml) but not other cancer cell lines
Evidence 9 Activity

Activity

IC50
IC50=34.4 µg/ml
Anticancer
34.4 µg/mL

Target

Leukemia Cancer
C8166
Blood

Assay & Model

MTT/MTS assay
48-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation. dbAMP 3.0 classified as Anticancer under the disease-associated peptide function classes.
Evidence 10 Activity

Activity

IC50
IC50 >50 µg/ml
Anticancer
50 µg/mL

Target

Leukemia Cancer
MOLT-4
Blood

Assay & Model

MTT/MTS assay
48-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001
Evidence 11 Activity

Activity

IC50
IC50 =>50 µg/ml
Anticancer
>50 µg/mL

Target

Bladder Cancer
BIU-87
Bladder

Assay & Model

MTT/MTS assay
48-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001
Evidence 12 Activity

Activity

IC50
IC50=>50 µg/ml
Anticancer
>50 µg/mL

Target

Bladder Cancer
T-24
Bladder

Assay & Model

MTT/MTS assay
48-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2001
Evidence 13 Activity

Activity

MIC
Antifungal
3.6 µM

Target

Staphylococcus aureus ATCC2592

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E.coli ATCC25922 (ND), S. aureus ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 1
Evidence 14 Activity

Activity

MIC
Antifungal
7.2 µM

Target

B. pyocyaneus CMCCB10104

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E.coli ATCC25922 (ND), S. aureus ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. a
Evidence 15 Activity

Activity

MIC
Antifungal
12 µM

Target

B. megatherium

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

li ATCC25922 (ND), S. aureus ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM
Evidence 16 Activity

Activity

MIC
Antifungal
12 µM

Target

B. dysenterium

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 1
Evidence 17 Activity

Activity

MIC
Antifungal
3.6 µM

Target

Klebsiella pneumoniae

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFF
Evidence 18 Activity

Activity

MIC
Antifungal
1.2 µM

Target

Candida albicans ATCC2002

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFFI2001 (MIC 12 ug/ml). active only a
Evidence 19 Activity

Activity

MIC
Antifungal
12 µg/mL

Target

A. flavus IFFI4015

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFFI2001 (MIC 12 ug/ml). active only against cancer cells C8166 (IC50 34.
Evidence 20 Activity

Activity

MIC
Antifungal
12 µg/mL

Target

P. uticale IFFI2001

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

e (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFFI2001 (MIC 12 ug/ml). active only against cancer cells C8166 (IC50 34.4 ug/ml) but not other cancer cell lines
Evidence 21 Activity

Activity

MIC
Antiparasitic
3.6 µM

Target

Staphylococcus aureus ATCC2592

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Active against E.coli ATCC25922 (ND), S. aureus ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 1
Evidence 22 Activity

Activity

MIC
Antiparasitic
7.2 µM

Target

B. pyocyaneus CMCCB10104

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against E.coli ATCC25922 (ND), S. aureus ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. a
Evidence 23 Activity

Activity

MIC
Antiparasitic
12 µM

Target

B. megatherium

Source & Reference

dbAMP 3.0 DRAMP

Other

li ATCC25922 (ND), S. aureus ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM
Evidence 24 Activity

Activity

MIC
Antiparasitic
12 µM

Target

B. dysenterium

Source & Reference

dbAMP 3.0 DRAMP

Other

ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 1
Evidence 25 Activity

Activity

MIC
Antiparasitic
3.6 µM

Target

Klebsiella pneumoniae

Source & Reference

dbAMP 3.0 DRAMP

Other

ocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFF
Evidence 26 Activity

Activity

MIC
Antiparasitic
1.2 µM

Target

Candida albicans ATCC2002

Source & Reference

dbAMP 3.0 DRAMP

Other

uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFFI2001 (MIC 12 ug/ml). active only a
Evidence 27 Activity

Activity

MIC
Antiparasitic
12 µg/mL

Target

A. flavus IFFI4015

Source & Reference

dbAMP 3.0 DRAMP

Other

. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFFI2001 (MIC 12 ug/ml). active only against cancer cells C8166 (IC50 34.
Evidence 28 Activity

Activity

MIC
Antiparasitic
12 µg/mL

Target

P. uticale IFFI2001

Source & Reference

dbAMP 3.0 DRAMP

Other

e (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFFI2001 (MIC 12 ug/ml). active only against cancer cells C8166 (IC50 34.4 ug/ml) but not other cancer cell lines
Evidence 29 Activity

Activity

MIC
Antiviral
3.6 µM

Target

Staphylococcus aureus ATCC2592

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
Active against E.coli ATCC25922 (ND), S. aureus ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 1
Evidence 30 Activity

Activity

MIC
Antiviral
7.2 µM

Target

B. pyocyaneus CMCCB10104

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Active against E.coli ATCC25922 (ND), S. aureus ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. a
Evidence 31 Activity

Activity

MIC
Antiviral
12 µM

Target

B. megatherium

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

li ATCC25922 (ND), S. aureus ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM
Evidence 32 Activity

Activity

MIC
Antiviral
12 µM

Target

B. dysenterium

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ATCC2592 (MIC3.6 uM), B. pyocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 1
Evidence 33 Activity

Activity

MIC
Antiviral
3.6 µM

Target

Klebsiella pneumoniae

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ocyaneus CMCCB10104 (MIC 7.2 uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFF
Evidence 34 Activity

Activity

MIC
Antiviral
1.2 µM

Target

Candida albicans ATCC2002

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

uM), B. megatherium (MIC 12 uM), B. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFFI2001 (MIC 12 ug/ml). active only a
Evidence 35 Activity

Activity

MIC
Antiviral
12 µg/mL

Target

A. flavus IFFI4015

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

. dysenterium (MIC 12 uM), K. pneumoniae (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFFI2001 (MIC 12 ug/ml). active only against cancer cells C8166 (IC50 34.
Evidence 36 Activity

Activity

MIC
Antiviral
12 µg/mL

Target

P. uticale IFFI2001

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

e (MIC 3.6 uM), C. albicans ATCC2002 (MIC 1.2 uM), A. flavus IFFI4015 (MIC 12 ug/ml), and P. uticale IFFI2001 (MIC 12 ug/ml). active only against cancer cells C8166 (IC50 34.4 ug/ml) but not other cancer cell lines
Evidence 37 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref:11835991]Little hemolytic activity at 50 µg/ml against red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Eur J Immunol. 2005 Apr 35(4):1220-9.##Peptides. 2002 Mar 23(3):427-435.